Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 19, 2000

View Archived Issues

Xechem awarded SBIR grant for marine extremophile research

Phase I trial shows excellent safety profile for NeoRx's STR agent

Avant Immunotherapeutics reports on TP-10 progress

Tripos and Parke-Davis to jointly develop high-throughput screening methods

Inflazyme selects nonemetic PDE4 inhibitor, updates status of other products

Enzo Biochem receives grant for HBV therapy

Provigil under study for several indications

TXU (anti-CD7)-PAP possesses good pharmacokinetics, low toxicity

AxyS announces combinatorial chemistry agreement with Searle

Hollis-Eden product shows efficacy in chloroquine-resistant malaria

IL-5 receptor antagonists discovered at Structural Bioinformatics

Therapeutically useful substituted oxazolidinones emerge from R&D at AstraZeneca

New beta-carbolines are somatostatin receptor ligands and sodium channel blockers

SB discloses newest selective dopamine D3 receptor ligands

Distamycin derivatives in development at Pharmacia & Upjohn

Glycine-antagonist tetrahydroquinoline derivatives designed at Glaxo Wellcome

Byk Gulden patents new PDE4 inhibitors

Merck KGaA designs nontoxic hypoglycemic agents particularly useful for NIDDM

Efforts at DuPont to design potent and selective alphavbeta3 antagonists successful

CKD-731: new fumagillin analogue shows potential as antiangiogenic agent

Antiplatelet agent OPC-29030 appears to act by inhibiting 12-lipoxygenase translocation

FemSoft Insert now commercially available in U.S. for treatment of incontinence

Avax Technologies' O-Vax IND accepted

First clinical results with 90Y-DOTATOC indicate antitumor efficacy, some safety problems

KeraVision commences clinical trials for use of Intacs as treatment of keratoconus

Avant's cholera vaccine to enter phase IIb trial

HIV gene medicine from Enzo progresses favorably in phase I trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
DOJ arrests shed light on Medicare skin substitute controversy
BioWorld MedTech
Much has been made of the recent skyrocketing of Medicare spending on skin substitutes, but a new enforcement action by the U.S. Department of Justice might help...